Targeting Bcl-2 for cancer therapy

L Zhang, Z Lu, X Zhao - Biochimica et Biophysica Acta (BBA)-Reviews on …, 2021 - Elsevier
Apoptosis deficiency is one of the most important features observed in neoplastic diseases.
The Bcl-2 family is composed of a subset of proteins that act as decisive apoptosis …

Targeting Bcl-2 for cancer therapy.

L Zhang, Z Lu, X Zhao - Biochimica et Biophysica acta. Reviews on …, 2021 - europepmc.org
Apoptosis deficiency is one of the most important features observed in neoplastic diseases.
The Bcl-2 family is composed of a subset of proteins that act as decisive apoptosis …

Targeting Bcl-2 for cancer therapy

L Zhang, Z Lu, X Zhao - Biochimica et biophysica acta …, 2021 - pubmed.ncbi.nlm.nih.gov
Apoptosis deficiency is one of the most important features observed in neoplastic diseases.
The Bcl-2 family is composed of a subset of proteins that act as decisive apoptosis …